Cataract Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
상품코드:1576924
리서치사:DelveInsight
발행일:On Demand Report
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
백내장 수술 기기 시장 규모는 2023년에 77억 3,000만 달러에 달했습니다. 이 시장은 2024-2030년의 예측 기간 중 5.50%의 CAGR로 확대하며, 2030년에는 106억 6,000만 달러에 달할 것으로 예측됩니다. 백내장 수술 기기의 수요는 주로 백내장과 시력 장애의 유병률 상승, 고혈압 및 당뇨병 등 백내장을 발병하는 생활습관병의 유병률 상승에 의해 지원되고 있습니다. 고령자 인구의 증가, 제품 개발의 R&D 활동 및 기술 혁신은 2024-2030년의 예측 기간 중 백내장 수술 기기 시장의 플러스 성장에 기여하는 다른 주요 요인 중 일부입니다.
백내장 및 시력 장애의 유병률 증가는 백내장 수술 기기 시장의 성장에 크게 기여하고 있습니다. 세계보건기구(WHO)에 따르면 2023년 전 세계 22억 명 이상이 근시 또는 원시의 영향을 받고 있으며, 2024년 5월 영국 정부가 발표한 자료에 따르면 2023년 영국에서만 516,073명 이상이 백내장 수술을 위해 병원에 입원했습니다. 백내장 수술 기기는 혼탁한 수정체를 분쇄하여 제거하거나 백내장 제거 후 인공수정체(IOL)를 이식하여 이 문제를 해결하는 데 도움이 됩니다. 결과적으로 백내장 및 시력 장애 발병률 증가는 이러한 수술 장비 시장 성장을 크게 촉진할 것으로 예상됩니다.
노화는 백내장의 주요 위험 요소이며, 백내장은 일반적으로 노화 황반변성, 특히 60세 이후에 발병합니다. 미국 국립보건원(NIH)이 2023년 11월에 발표한 데이터에 따르면 2023년 미국에서는 80세 이상 인구의 50% 이상이 백내장을 앓고 있거나 백내장 수술을 받은 것으로 나타났습니다. 또한 WHO의 2022년 보고서에 따르면 전 세계 60세 이상 인구는 2015년에서 2050년 사이에 12%에서 22%로 두 배로 증가하여 2050년에는 21억 명에 달할 것으로 예상되며, 2030년에는 6명 중 1명이 60세 이상이 될 것으로 예측됩니다. 백내장은 노년층에서 많이 발생하므로 이러한 인구통계학적 변화는 백내장 수술에 대한 수요를 증가시키고, 그 결과 백내장 수술용 장비에 대한 수요를 증가시켜 시장 성장을 가속할 것으로 예상됩니다.
세계의 백내장 수술 기기 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
목차
제1장 백내장 수술 기기 시장 보고서 서론
제2장 백내장 수술 기기 시장의 개요
제3장 경쟁 구도
제4장 규제 분석
미국
유럽
일본
중국
제5장 백내장 수술 기기 시장의 주요 요인 분석
백내장 수술 기기 시장 성장 촉진요인
백내장 수술 기기 시장 성장 억제요인과 과제
백내장 수술 기기 시장 기회
제6장 백내장 수술 기기 시장의 Porter's Five Forces 분석
제7장 백내장 수술 기기 시장 평가
제품 유형별
최종사용자별
지역별
제8장 백내장 수술 기기 시장의 기업과 제품 개요
Alcon Inc.
Johnson & Johnson Services, Inc.
NIDEK CO., LTD.
ZEISS Group
Bausch Health Companies Inc.
Ziemer Ophthalmic Systems AG
Abbott Laboratories
HOYA Corporation
Aurolab
Hanita Lenses Ltd
Topcon Corporation
STAAR SURGICAL
Bohus BioTech AB
Eyekon Medical
CIMA Technology Inc.
Medisonic Equipments Pvt. Ltd.
Opthalmika Ltd
Lumenis Be Ltd.
Essilor International
Oertli Instrumente AG
제9장 KOL의 견해
제10장 프로젝트 어프로치
제11장 DelveInsight 소개
제12장 면책사항과 문의
KSA
영문 목차
영문목차
Cataract Surgery Devices Market by Product Type (Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Ophthalmic Viscosurgical Devices, and Others), End-User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to growing prevalence of cataract and increasing geriatric population.
The cataract surgery devices market was valued at USD 7.73 billion in 2023, growing at a CAGR of 5.50% during the forecast period from 2024 to 2030 to reach USD 10.66 billion by 2030. The demand for cataract surgery devices is primarily being boosted by the growing prevalence of cataracts and vision impairment and the increasing prevalence of lifestyle disorders that develop cataracts such as hypertension and diabetes. The rising geriatric population and R&D activities and technological innovation in product development are some of the other key factors that are responsible for contributing to the positive growth of the cataract surgery devices market during the forecast period from 2024 to 2030.
Cataract Surgery Devices Market Dynamics:
The rising prevalence of cataracts and vision impairment is significantly contributing to the growth of the cataract surgery devices market. According to the World Health Organization (WHO), in 2023, over 2.2 billion people globally were affected by near or distance vision impairment. In England alone, as per data published by the Government of the United Kingdom in May 2024, more than 516,073 people were admitted to hospitals for cataract surgery in 2023. Cataract surgery devices help address this issue by either fragmenting and removing the cloudy lens or by implanting an artificial intraocular lens (IOL) after cataract removal. As a result, the growing incidence of cataracts and vision impairment is expected to drive significant market growth for these surgical devices.
Aging is the primary risk factor for cataracts, which typically develop due to age-related macular degeneration, especially after age 60. Data provided by the National Institute of Health (NIH) in November 2023 revealed that over 50% of individuals aged 80 and above either had cataracts or had undergone cataract surgery in the United States in 2023. Moreover, WHO's 2022 report projected that the global population aged 60 and above will double from 12% to 22% between 2015 and 2050, reaching 2.1 billion by 2050. By 2030, one in six individuals will be aged 60 or older. Since cataracts occur predominantly in older people, this demographic shift is expected to increase the demand for cataract surgeries and, consequently, drive the demand for cataract surgery devices, boosting market growth.
Lifestyle disorders, particularly diabetes and hypertension, also contribute to the development of cataracts. High blood sugar levels associated with diabetes cause structural changes in the eye's lens, accelerating cataract formation. According to data from the International Diabetes Federation (IDF) in 2023, approximately 537 million adults aged 20 to 79 were living with diabetes in 2021. This number is projected to rise to 643 million by 2030 and 783 million by 2045. Diabetes is a major risk factor for cataracts, as it impacts various ocular structures, making cataracts a common complication of the condition. Therefore, the increasing prevalence of diabetes and other lifestyle-related diseases is expected to further drive market growth.
Key players in the cataract surgery market are focusing their research and development (R&D) efforts on creating advanced solutions to improve surgical precision and patient outcomes. For example, in January 2021, Alcon launched the AcrySof(R) IQ Vivity(TM) IOL in the United States. Vivity is a non-diffractive extended depth-of-focus intraocular lens based on X-WAVE(TM) technology, offering monofocal-quality distance vision along with enhanced intermediate and functional near vision, thus providing a comprehensive visual experience without light splitting. Such product innovations by leading companies are expected to fuel market growth.
However, complications associated with cataract surgery and the limited availability of these devices in developing countries may pose challenges to the growth of the cataract surgery devices market.
Cataract Surgery Devices Market Segment Analysis:
Cataract Surgery Devices Market by Product Type (Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Ophthalmic Viscosurgical Devices, and Others), End-User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment of the cataract surgery devices market, femtosecond lasers are expected to account for a significant share during the forecast period, driven by the increasing number of cataract surgeries performed globally. According to data from the European Commission in 2023, cataract surgery was the most commonly performed surgical procedure, with 4.32 million surgeries conducted across Europe in 2021. Femtosecond lasers enhance cataract surgery by performing key tasks such as capsulorrhexis (the opening of the lens capsule) and fragmenting the lens, thus facilitating its removal and improving the efficiency of the procedure.
The growing adoption of laser-assisted cataract surgery over conventional methods is attributed to the many benefits femtosecond lasers offer. This advanced technique minimizes damage to surrounding tissues and reduces the risk of complications such as ectasia. Laser-assisted cataract surgery, which utilizes computer-guided, bladeless operations, ensures greater precision, resulting in more accurate incisions compared to traditional corneal methods. The increased precision and reduced risk contribute to its growing popularity in the field of cataract surgery.
Femtosecond lasers provide a high degree of precision and consistency when creating incisions in the cornea and lens capsule, leading to improved procedural outcomes and fewer complications. This technique not only accelerates the healing process but also offers the added benefit of astigmatism correction in cataract patients. These advantages are expected to drive demand for laser-assisted cataract surgery devices, thereby fueling market growth during the forecast period.
Leading players in the market are focusing on the development and commercialization of advanced femtosecond lasers to improve surgical precision, safety, and patient outcomes. For instance, in April 2023, Johnson & Johnson MedTech received FDA 510(k) clearance for their ELITA Femtosecond Laser system. The ELITA system is designed with low energy per pulse and an ultra-fast laser repetition rate to minimize complications and enhance both visual recovery and patient outcomes. Such innovations are expected to drive significant growth in the femtosecond laser segment, contributing to the overall expansion of the cataract surgery devices market.
North America is expected to dominate the overall cataract surgery devices market:
North America is expected to hold the largest share of the cataract surgery devices market in 2023, driven by the rising prevalence of cataracts and vision impairments, alongside increasing risk factors such as diabetes, hypertension, and obesity in the region. The growing aging population, which is more susceptible to developing cataracts, and technological innovations in product development further contribute to the market's expansion in North America.
According to data from the Centers for Disease Control and Prevention (CDC) in May 2024, an estimated 20.5 million individuals aged 40 and older in the United States were affected by cataracts in one or both eyes in 2022. This number is projected to rise in the coming years, creating increased demand for cataract removal treatments and driving growth in the cataract surgery devices market.
Additionally, the rising rates of obesity and overweight individuals in North America are contributing to the demand for cataract surgery devices. Obesity is linked to systemic inflammation, which can promote cataract development. According to data from the Government of Canada in May 2024, one in every three Canadians was considered obese in 2022. The increasing prevalence of such risk factors, which are associated with cataract formation, is expected to further fuel market growth in the region.
Key players in the cataract surgery devices market are investing in research and development to create and commercialize advanced solutions, thereby boosting market growth. For instance, in May 2021, Johnson & Johnson MedTech received FDA approval for the Tecnis Synergy and Tecnis Synergy Toric II intraocular lenses (IOLs), aimed at improving outcomes for cataract patients. Similarly, in April 2021, Alcon Canada launched several presbyopia-correcting lenses, including the AcrySof(R) IQ PanOptix(R) UV IOL, AcrySof(R) IQ PanOptix(R) Toric UV IOL, AcrySof(R) IQ Vivity(R) UV IOL, and AcrySof(R) IQ Vivity(R) Toric UV IOL, expanding cataract treatment options for Canadian patients.
These advancements, combined with the growing need for cataract surgery devices driven by rising cataract cases and risk factors, are expected to significantly contribute to the market's growth in North America.
Cataract Surgery Devices Market Key Players:
Some of the key market players operating in the cataract surgery devices market include Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG, Abbott Laboratories, HOYA Corporation, Aurolab, Hanita Lenses Ltd, Topcon Corporation, STAAR SURGICAL, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc., Medisonic Equipments Pvt. Ltd., Opthalmika Ltd, Lumenis Be Ltd., Essilor International, Oertli Instrumente AG, and others.
Recent Developmental Activities in the Cataract Surgery Devices Market:
In July 2024, Oertli Instrumente AG announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Faros anterior cataract surgery system. It is a high-performance surgical platform designed for cataract, vitreoretinal, and glaucoma procedures. Its advanced fluid and vacuum control capabilities provide advanced precision, allowing it to adapt seamlessly to varying cataract hardness levels.
In June 2024, Alcon received U.S. Food and Drug Administration (FDA) 510(k) clearance for UNITY(R) Vitreoretinal Cataract System (VCS) and UNITY(R) Cataract System (CS). This system is developed to offer enhanced precision for vitreoretinal procedures in cataract surgery.
In April 2023, Bausch + Lomb Corporation launched the StableViscTM cohesive ophthalmic viscosurgical device (OVD) as well as the TotalViscTM Viscoelastic System in the United States. These devices are designed to maintain space in the anterior chamber of the eye. This facilitates the effective extraction and replacement of the clouded natural lens during cataract surgery.
Key Takeaways from the Cataract Surgery Devices Market Report Study
Market size analysis for current Cataract Surgery Devices Market size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
Key companies dominating the Cataract Surgery Devices market.
Various opportunities available for the other competitors in the Cataract Surgery Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current Cataract Surgery Devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Cataract Surgery Devices market growth in the coming future?
Target Audience who can be benefited from this Cataract Surgery Devices Market Report Study
Cataract Surgery Devices product providers
Research organizations and consulting companies
Cataract Surgery Devices related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Cataract Surgery Devices
Various end-users who want to know more about the Cataract Surgery Devices Market and the latest technological developments in the Cataract Surgery Devices Market.
Frequently Asked Questions for the Cataract Surgery Devices Market:
1. What are Cataract Surgery Devices?
Cataract surgery devices are medical devices that are employed during cataract surgery and carry out tasks in different steps during the surgery such as breaking the cataract into small pieces which are performed by phacoemulsification devices and the replacement by artificial lenses such as intraocular lenses among other products.
2. What is the market for Cataract Surgery Devices?
The Cataract Surgery Devices Market was valued at USD 7.73 billion in 2023, growing at a CAGR of 5.50% during the forecast period from 2024 to 2030 to reach USD 10.66 billion by 2030.
3. What are the drivers for the Cataract Surgery Devices market?
The cataract surgery devices market is slated to witness prosperity owing to factors such as the growing prevalence of cataracts and vision impairment and the increasing prevalence of lifestyle disorders that develop cataracts such as hypertension and diabetes. The rising geriatric population and R&D activities and technological innovation in product development are some of the key factors resulting in appreciable revenue growth in the Cataract Surgery Devices Market during the forecast period (2024 to 2030).
4. Who are the key players operating in the Cataract Surgery Devices market?
Some of the key market players operating in the cataract surgery devices market include Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG, Abbott Laboratories, HOYA Corporation, Aurolab, Hanita Lenses Ltd, Topcon Corporation, STAAR SURGICAL, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc., Medisonic Equipments Pvt. Ltd., Opthalmika Ltd, Lumenis Be Ltd., Essilor International, Oertli Instrumente AG, and others.
5. Which region has the highest share in the Cataract Surgery Devices market?
North America is expected to account for the largest share in the cataract surgery devices market in 2023, among all the regions. This is attributed to the rising prevalence of cataracts and vision impairments in the region coupled with increasing prevalence of risk factors such as diabetes, hypertension, and obesity. The growing aging population which is more prone to develop cataracts and technological innovation in the product development in the region are some of the key factors driving the growth of the cataract surgery devices market in North America.
Table of Contents
1. Cataract Surgery Devices Market Report Introduction
1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption
2. Cataract Surgery Devices Market Executive Summary
2.1. Market at Glance
3. Competitive Landscape
4. Regulatory Analysis
4.1. The United States
4.2. Europe
4.3. Japan
4.4. China
5. Cataract Surgery Devices Market Key Factors Analysis
5.1. Cataract Surgery Devices Market Drivers
5.1.1. The growing prevalence of cataracts and vision impairment
5.1.2. Increasing prevalence of lifestyle disorders that develop cataracts
5.1.3. Rising geriatric population
5.1.4. R&D activities and technological innovation in product development
5.2. Cataract Surgery Devices Market Restraints and Challenges
5.2.1. Complications associated with cataract surgery
5.2.2. Limited availability of these devices in developing countries
5.3. Cataract Surgery Devices Market Opportunity
5.3.1. Emergence of robotic-assisted laser surgeries
5.3.2. Laser-assisted cataract surgeries in underdeveloped countries
6. Cataract Surgery Devices Market Porter's Five Forces Analysis
6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry
7. Cataract Surgery Devices Market Assessment
7.1. By Product Type
7.1.1. Phacoemulsification Systems
7.1.2. Femtosecond Lasers
7.1.3. Intraocular Lenses
7.1.4. Ophthalmic Viscosurgical Devices
7.1.5. Others
7.2. By End-User
7.2.1. Hospitals
7.2.2. Specialty Clinics
7.3. By Geography
7.3.1. North America
7.3.1.1. United States Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.1.2. Canada Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.1.3. Mexico Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.2. Europe
7.3.2.1. France Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.2.2. Germany Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.2.3. United Kingdom Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.2.4. Italy Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.2.5. Spain Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.2.6. Rest of Europe Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.3. Asia-Pacific
7.3.3.1. China Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.3.2. Japan Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.3.3. India Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.3.4. Australia Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.3.5. South Korea Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.3.6. Rest of Asia-Pacific Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.4. Rest of the World (RoW)
7.3.4.1. Middle East Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.4.2. Africa Cataract Surgery Devices Market Size in USD million (2021-2030)
7.3.4.3. South America Cataract Surgery Devices Market Size In USD Million (2021-2030)
8. Cataract Surgery Devices Market Company and Product Profiles
